Currently, the available drugs for AD are predominantly AChE and/or BChE inhibitors, such as donepezil, a selective AChE inhibitor, and rivastigmine, a dual inhibitor of both AChE and BChE. This evidence concerns the gene ACHE and Alzheimer disease.